Preprint
Article

This version is not peer-reviewed.

Relationship Between Frailty and Risk of Falls Among Hospitalised Older People with Cardiac Conditions: An Observational Cohort Study

A peer-reviewed article of this preprint also exists.

Submitted:

30 December 2024

Posted:

02 January 2025

You are already at the latest version

Abstract
Background/Objetive: Population ageing promotes the occurrence of cardio-vascular diseases, frailty, and risk of falls.To determine the relationship between frailty, risk of falls, and length of hospital stay in hospitalised older adults with cardiac condi-tions. Methods: Observational study of a cohort of patients aged ≥60 years admitted to a cardiology unit (2022–2024). Frailty was assessed using the Fried Frailty Phenotype, risk of falls using the J.H. Downton scale, and dependency level using the Barthel index. Clin-ical variables and anthropometric measurements were analysed alongside length of stay. Statistical analysis: quantitative variables were expressed as means and standard devia-tions, and categorical variables as frequencies. Associations were analysed using Stu-dent’s t-tests, chi-squared tests, and Kruskal-Wallis tests for comparisons of three or more groups. Relationships between frailty, risk of falls, and other variables were examined us-ing univariate binary logistic regression, with a 95% confidence interval and statistical significance set at p < 0.05. Results: A total of 144 patients were recruited (mean age=73.08 years [SD=7.95]) (women=33.30%). Frailty was associated with waist circumference in men (p=0.01) and diastolic blood pressure in women (p=0.05). Frailty was further linked to Downton scores (odds ratio [OR]=1.565; 95% CI:1.156–2.120; p=0.004), age (OR=1.114; 95% CI:1.058–1.173; p=0.000), Barthel index (OR=0.902; 95% CI:0.854–0.953; p=0.000), and length of stay (OR=1.101; 95% CI:1.021–1.186; p=0.012).Conclusions: Frailty ap-pears to be related to Downton scores and impacts the length of hospital stay in older adults hospitalised with cardiac conditions.
Keywords: 
;  ;  ;  ;  

1. Introduction

Frailty syndrome, cardiovascular diseases (CVDs), and falls are three of the most prevalent health issues among older adults [1], with significantly different outcomes between sexes [2,3,4].
The ageing process begins at 60 years of age, a stage marked by declining physical condition and an increased risk of disease. Globally, the number of people aged 60 and above reached 1 billion in 2019 and is projected to rise to 2.5 billion by 2050 [5].
CVDs are one of the most common conditions worldwide during this period, directly linked to morbidity, disability, and mortality [6]. The risk of CVD is particularly elevated among women due to the physiological changes associated with menopause [7, 8].
In later life, an imbalance in homeostasis can lead to the emergence of frailty syndrome, first defined by Linda Fried et al. as a physical phenotype in 2001. Various tools for identifying frailty exist in the literature, with Fried’s five-criteria scale being among the most widely used [9].
Frailty has been associated with adverse outcomes such as increased risk of hospitalisation, falls, and mortality, all of which lead to higher healthcare costs [10].
Ongoing research into defining frailty and developing tools to address its multifactorial nature reveals varying prevalence rates depending on the study setting. Doody et al. (2023) reported a frailty prevalence of 10.7% among community-dwelling older adults, compared to 47.4% among hospitalised older patients [1]. Despite having a longer life expectancy, women are more frequently affected by frailty [2], with a prevalence of 9.6% compared to 5.4% in men [11].
Xu, Ou, and Li provided evidence that CVD, frailty, and hypertension increase the risk of falls [12]. Similarly, a study in the United Kingdom found that pre-frail and frail patients had a 47% and 15% higher risk of developing CVD, respectively, compared to non-frail patients [13]. Other researchers have linked CVD to an elevated risk of mortality (relative risk [RR]=1.81; 95% CI:1.67–1.97) among fall-related incidents, with age being a contributing factor [14,15].
Falls compromise personal safety and are more common among older adults [16], with a higher prevalence among women [17]. In hospital settings, falls are the most frequent adverse event, with an incidence of 3–5 falls per 1,000 patient-days and an estimated annual occurrence of 700,000 to 1 million cases [18, 19].
Preventing falls has been a key area of study. Multifactorial programmes such as 6-PACK and Best Practice Spotlight Organisations (BPSO®) include guidelines like the Prevention of Falls and Fall Injuries Best Practice Guideline [20, 21]. A common recommendation across these programmes is to identify patients at risk of falling so as to implement targeted interventions [22, 23].
The interplay between CVD, frailty, and falls poses a significant challenge to therapeutic actions for these patients. These challenges are further influenced by sex differences and the traditional threshold for ageing set at 65 years, even though physiological changes begin at 60 years. Addressing these factors could have a profound impact on population health and the economic resources of healthcare systems. For these reasons, this study aimed to analyse the relationship between frailty, risk of falls, and length of hospital stay in hospitalised older adults with cardiac conditions.

2. Materials and Methods

2.1. Study Design, Setting, and Sampling

An observational cohort study was conducted in a tertiary hospital within the public network of the Spanish National Health System. Recruitment took place between March 2022 and September 2024, involving patients admitted to a conventional cardiology hospitalisation unit. Individuals aged ≥60 years who were conscious and oriented were included. The study is reported according to STROBE reporting guidelines for observational research.
The study participants were selected using a non-probabilistic convenience sampling method in the cardiology unit.

2.2. Instruments

2.2.1. Fall Risk Assessment

Fall risk screening was conducted using the BPSO® programme, introduced in Spain in 2010 through the Carlos III Health Institute under the Ministry of Science, Innovation, and Universities. The programme was implemented in the study hospital in 2018, with the Prevention of Falls and Fall Injuries guideline being adopted in 2019. Fall risk was evaluated using the J.H. Downton scale, which assesses five dimensions: previous falls, medication, sensory deficits, mental state, and gait [24]. The J.H. Downton scale has a sensitivity of 0.58 and specificity of 0.63. Scores were interpreted as follows: 0 points = no risk, 1–2 points = low/moderate risk, and ≥3 points = high risk [25].

2.2.2. Frailty Identification

Patients classified as frail were identified using Fried’s five criteria [9]:
1. Unintentional weight loss >4.5 kg or >5.0% (in the past year).
2. Generalised exhaustion (low energy and endurance measured by the CES-D depression scale [26]).
3. Weakness (handgrip strength adjusted for sex and body mass index using a hand dynamometer).
4. Walking speed (time to cover 4.57 m adjusted for sex and height).
5. Weekly physical activity (Minnesota Leisure Time Activity Questionnaire [MLTAQ] stratified by sex; men: 383 kcal/week, women: 270 kcal/week [27]).
Patients were classed based on the number of criteria they met:
  • Frail: three or more criteria.
  • Pre-frail: one or two criteria.
  • Non-frail: no criteria.

2.2.3. Functional Dependency

Functional dependency was assessed using the Barthel Index, which has a Cronbach’s alpha of 0.70 [28]. Scores were categorised as:
  • 0-20: total dependence
  • 21-60: severe dependence
  • 61-90: moderate dependence
  • 91-99: minimal dependence
  • 100: independence

2.3. Description of Variables

  • Sociodemographic variables: sex (biological attribute); age.
  • Dependent variable: fall risk (yes/no); score on the J.H. Downton scale.
  • Independent variables:
1. Frailty status.
2. Clinical variables: main diagnosis (coronary heart disease; infectious endocarditis; heart failure; arrhythmias; heart transplant; and valvular diseases); diabetes mellitus (yes/no); readmission to the cardiology unit (yes/no); presence of dyspnoea at admission (yes/no); presence of chest pain at admission (yes/no); systolic blood pressure (SBP; mmHg); diastolic blood pressure (DBP; mmHg); heart rate (HR; beats per minute); oxygen saturation (SpO₂; %); and blood glucose (mg/dL).
3. Anthropometric variables: height (cm); weight (kg); waist circumference (cm); body mass index (BMI; kg/m²: overweight (≥25 kg/m²), obesity (≥30 kg/m²)).
4. Length of stay: number of hospitalisation days.

2.4. Procedure

Data collection was conducted within the first three days of hospital admission. Patients meeting the inclusion criteria were informed about the study, and after obtaining their informed consent, the following data were extracted from their electronic health records: sex, age, primary diagnosis, diabetes mellitus status, readmission to the cardiology unit, presence of dyspnoea, SBP, DBP, HR, SpO₂, and blood glucose levels. At admission, the degree of dependency was systematically assessed using the Barthel index, and fall risk was screened using the J.H. Downton scale, with scores of 1 or higher considered positive.
Anthropometric measures such as height, weight, and BMI were recorded, and Fried’s scale was applied to identify frail patients. The length of stay in days was documented for all participants upon hospital discharge.

2.5. Ethical Considerations

The anonymity and confidentiality of participant data were safeguarded using Research Electronic Data Capture (REDCap) software, in compliance with the European Regulation 2016/679 of the European Parliament and of the Council of 27 April 2016 and Spanish Organic Law 3/2018, of 5 December, on the Protection of Personal Data and the Guarantee of Digital Rights. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the relevant Valladolid Ethics Committee for Research with medicinal products (ECRmp) involving humans under the reference code PI-20-1612 on 23 January 2020.

2.5. Statistical Analysis

Data normality was assessed using the Kolmogorov-Smirnov test, kurtosis, and skewness. Quantitative variables were presented as means and standard deviations (SD), while categorical variables were expressed as frequency distributions. Quantitative variables were compared using Student’s t-test, categorical variables with Pearson’s chi-squared test, and comparisons among three groups using the Kruskal-Wallis test. Homogeneity of variance was evaluated using Levene’s test.
Univariate binary logistic regression was employed to identify factors associated with frailty and fall risk, with adjusted odds ratios (OR) calculated for the included variables. A confidence interval of 95% and a statistical significance level of p<0.05 were applied.
Statistical analyses were performed using IBM® SPSS® Statistics v.26 software (SPSS, Inc., Chicago, IL, USA).

3. Results

3.1. Descriptive Analysis

During the study period, 144 patients agreed to participate (33.30% women, n=48; 66.70% men, n=96) with a mean age of 73.08 years (SD=7.95). The most prevalent diagnosis was coronary heart disease (61.11%). Diabetes mellitus was present in 36.11% of patients, while 35.42% reported chest pain at admission, and 30.56% presented with dyspnoea.
Regarding frailty, 33.30% of patients were classed as frail. Fall risk was identified in 97.22% of participants, with 36.81% of the total sample considered at high or very high risk (Table 1).
The mean Downton score indicated a low/moderate fall risk (2.24 points; SD=1.25). The Barthel Index showed a mean score of 95.76 points (SD=9.28), reflecting a minimal level of dependency in most patients. The mean BMI fell within the overweight category ( X ¯ =27.69 kg/m²; SD=4.35), and the mean waist circumference exceeded 100 cm. The mean overall hospital stay was 8.66 days (SD=5.56), while patients at high fall risk experienced a longer mean stay of 9.71 days (SD=7.39) (Table 2).
After analysing the data by sex, the mean age was similar between men and women, as was the Downton score. Women were proportionally frailer and had a lower mean score on the Barthel index (93.54 points; SD=12.80). There were no differences in mean BMI (men: X ¯ =27.71 kg/m²; SD=4.09; women: X ¯ =27.67 kg/m²; SD=4.89). However, the mean waist circumference was larger in men than in women. The mean length of hospital stay was longer among men ( X ¯ =9.40 days; SD=6.13) compared to women ( X ¯ =7.11 days; SD=3.78). When analysed by frailty status, frail men had the longest mean hospital stays (Table 2 and Table 3).
The most prevalent diagnosis was coronary heart disease. The proportion of patients with diabetes was higher among men (39.58%). Fall risk was greater among frail and pre-frail women compared to other groups (37.50% and 43.80%, respectively) (Table 4).
When analysing frailty distribution within the high/very high fall risk group, 45.30% of the patients were classified as frail. Women in this group exhibited a higher percentage of pre-frailty compared to men. This group of patients had a mean hospital stay of 12.06 days (SD=9.05) (Table 5).
According to the J.H. Downton scale, the most frequently used category of medications among patients was other medications (27.10%), followed by non-diuretic antihypertensives taken in combination with other drugs (16.00%). Notably, 99.30% of the patients were taking at least one medication during the assessment (Table 6).

3.2. Comparison Between Frailty Status and Demographic and Clinical Variables

A comparative analysis between categorical variables and frailty status revealed statistically significant differences in gait (assessed within the Downton scale) (χ2=25.14; df=10; p<0.00); social risk (χ2=8.88; df=2; p<0.01), and gender (χ2= 5.99; df=2; p<0.05). However, no significant differences were found with risk of falls (χ2=0.62; df=2; p=0.73).
Regarding quantitative variables, significant differences were observed between non-frail and frail patients in diastolic blood pressure (t=2.19; df=92; p=0.03); waist circumference (t=-2.22; df=91; p=0.02); length of hospital stay (t=-2.74; df=92; p=0.00), and height (t=2.96; df=92; p<0.00).
Among women, a significant association was observed between frailty status (frail and non-frail) and diastolic blood pressure (t=-2.06; df=25; p=0.05). In men, waist circumference was significantly associated with frailty status (frail vs. non-frail) (t=-2.61; df=65; p=0.01).
In the analysis of the three frailty groups (frail, pre-frail, and non-frail), statistically significant differences were found in the following variables: Downton score (H=7.73; df=2; p=0.02); Barthel index (H=25.68; df=2; p=0.00); length of hospital stay (H=6.97; df=2; p=0.03); waist circumference (H=6.78; df=2; p=0.03); age (H=19.75; df=2; p=0.00), and height (H=6.75; df=2; p=0.03) (Table 7).
Among women, a significant association was observed between frailty status and the Barthel index in the Pre-frail–Frail group (H=7.71; p=0.04). For men, a significant association was found in the Frail–Non-frail group (H=14.00; p<0.00).

3.3. Logistic Regression Analysis

No significant association was found between risk of falls and frailty status (OR: 0.959; 95% CI: 0.058-15.752; p=0.977). However, waist circumference was significantly associated with risk of falls (OR: 1.063; 95% CI: 1.003-1.125; p=0.038).
Frailty status was directly related to Downton scores, age, Barthel Index, oxygen saturation (SpO₂), diastolic blood pressure, and waist circumference. No statistically significant relationship was observed with sex (Table 8).
When examining the relationship between frailty and specific items from the Downton scale, the use of diuretics, sensory deficits in the extremities, and gait were significantly associated with frailty (Table 9).
A statistically significant relationship was observed between coronary heart disease and frailty status (Table 10).

4. Discussion

Scientific cardiology societies should prioritise including frail patients with cardiovascular disease (CVD) in their research projects in order to optimise their clinical management, particularly considering the existing link between frailty and risk of falls [29, 30].
Our study identified a relationship between frailty status and scores on the J.H. Downton scale, with frail hospitalised cardiac patients scoring higher and thus facing a greater risk of falls. However, no significant association was found between frailty status and binary fall risk (Yes/No), as determined by the same scale. This finding aligns with a study conducted on a rural Ecuadorian population aged ≥60 years (OR: 0.63; 95% CI: 0.29–1.36; p= 0.237), but contrasts with Yang et al.’s meta-analysis (RR: 1.48; 95% CI: 1.27–1.73; p<0.05) [14, 31]. These differences could be attributed to the use of varied tools for assessing both frailty and fall risk.
The limited predictive value of the J.H. Downton scale has been noted by other researchers, who have emphasised the critical role of nurses’ clinical judgement. In hospital settings, the Downton scale may overidentify fall risk, as the threshold begins at just 1 point. Despite its widespread use, pairing it with another tool that captures the multifactorial nature of fall risk is recommended [25, 32, 33].
Although no statistically significant relationship was found between frailty and fall risk by sex, differences were observed in related factors such as blood pressure and waist circumference. Previous studies have linked frailty in women to higher mortality (hazard ratio [HR]: 0.65; 95% CI: 0.58–0.74; p<0.001) [34].
Larger waist circumference in this study was associated with increased fall risk, consistent with Bu et al.’s findings (OR: 0.98; 95% CI: 0.96–1.00; p= 0.017) [35]. Polypharmacy is also a well-documented fall risk factor in CVD patients. In this study, frail patients were more likely to use diuretics than their non-frail counterparts. Diuretics are among the drugs most commonly linked to fall risk in this population, as highlighted by the American Heart Association [29].
The prevalence of frailty in our study was lower than reported in other non-community settings but higher than in community settings [1, 36]. Differences in frailty assessment tools, population groups, and identification criteria continue to hinder the development of standardised protocols [37].
Among the CVD diagnoses included in the study, frailty was only significantly associated with coronary heart disease. This contrasts with findings from Wang, Hu, and Wu, who found no overall relationship between frailty and CVD (RR: 1.00; 95% CI: 0.92–1.09; p=0.95) [38]. Liperoti et al. estimated that nearly one-fifth of patients with ischaemic heart disease were frail but did not establish a clear link [39]. While frailty is often associated with heart failure [40], this was not statistically significant in our study. Diastolic blood pressure was inversely related to frailty, suggesting that frail patients tended to have lower diastolic pressures. This finding aligns with previous studies [41], although Vetrano et al. reported a relationship between frailty and hypertension (pooled OR: 1.33; 95% CI: 0.94–1.89; I2=79.2%) [42]. Age also emerged as a significant factor, with increasing age linked to higher frailty risk, consistent with prior studies ([OR: 1.15; 95% CI: 1.09–1.21; p<0.001]; [OR: 3.910; 95% CI: 2.021–5.402; p<0.05]) [31, 41].
Frail patients also experienced longer hospital stays, with men staying the longest. When combined with fall risk, hospital stays extended to a mean of 12.06 days, likely increasing institutional costs [10].

4.1. Limitations

The main limitation of this study was the sample size, which was selected through convenience sampling. A larger sample would have allowed for greater generalisability of results. However, the study objectives were successfully addressed. Future studies should examine factors influencing the relationship between frailty and fall risk for each clinical diagnosis and include a wider range of hospital settings.
Future lines of research
Larger, more diverse samples are essential to generalise findings and uncover the complex relationship between frailty, risk of falls, and cardiovascular conditions. Developing multifactorial models that combine clinical and demographic variables could transform personalised care for these patients.

5. Conclusions

Frailty was directly associated with Downton scores in hospitalised older adults patients with cardiac conditions. In this study, 33.30% of patients were classed as frail, and 97.22% were at risk of falls. Women at high fall risk were proportionally frailer than men in the same situation. Frail patients also had longer hospital stays than their non-frail counterparts.
As the older population grows worldwide, the number of individuals with CVD who are frail and at risk of falls is expected to increase. Identifying shared characteristics within this population can help standardise assessment tools and improve clinical management, leading to better outcomes for patients and institutions alike. Combining frailty and fall risk scales in hospitalised older adults with cardiac conditions can refine prognostic accuracy, address comorbidities, and reduce hospital stays. Tailoring interventions to the differences between men and women is equally important for effective management.

Author Contributions

N.R.-G. conducted the literature review. N.R.-G., M.L., & M.J.C. designed the study. N.R.-G., M.F.-C., & B.M.-G. analysed the findings. N.R.-G., M.L., M.J.C., & J.A.S.R. drafted the final version of the manuscript. N.R.-G., M.F.-C., & B.M.-G. adapted the manuscript to the journal’s style requirements. All authors have read and agreed to the published version of the manuscript.

Funding

The study was funded by a grant awarded by the Castile & León Regional Health Management Board under reference code GRS 2706/A/23. The financial sponsors had no involvement in the design, conduct, analysis, or interpretation of the data, nor in the preparation or writing of the manuscript.

Institutional Review Board Statement

The study was conducted in accordance with the principles set out in the Declaration of Helsinki and approved by the Valladolid Ethics Committee for Research with medicinal products (ECRmp) involving humans under the reference code PI-20-1612.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available upon request from the corresponding author.

Public Involvement Statement

No public involvement in any aspect of this research.

Guidelines and Standards Statement

This manuscript was drafted against the STROBE (The Strengthening the Reporting of Observational Studies in Epidemiology) for observational research [43].

Use of Artificial Intelligence

TAI or AI-assisted tools were not used in drafting any aspect of this manuscript.

Acknowledgments

The authors would like to thank the cardiology department nurses at the Valladolid University Clinical Hospital for their invaluable collaboration.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
CVDs Cardiovascular diseases
BPSO® Best Practice Spotlight Organisations
RR Relative riks
SBP Systolic blood pressure
DBP Diastolic blood pressure
HR Heart rate
SpO2 Oxygen saturation
BMI Body mass index
RedCAP Research Electronic Data Capture
ECRmp Ethics Committee for Research with medicinal products
SD Standard deviation
OR Odds ratio
CI Confidence interval
HR Hazard ratio

References

  1. Doody, P.; Lord, J.M.; Greig, C.A.; Whittaker, A.C. Frailty: Pathophysiology, Theoretical and Operational Definition(s), Impact, Prevalence, Management and Prevention, in an Increasingly Economically Developed and Ageing World. Gerontology 2022, 69, 927–945. [Google Scholar] [CrossRef]
  2. Kane, A.E.; Howlett, S.E. Sex differences in frailty: Comparisons between humans and preclinical models. Mech. Ageing Dev. 2021, 198, 111546. [Google Scholar] [CrossRef] [PubMed]
  3. Regitz-Zagrosek, V.; Gebhard, C. Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes. Nat. Rev. Cardiol. 2022, 20, 236–247. [Google Scholar] [CrossRef]
  4. Jylhävä, J.; Pedersen, N.L.; Hägg, S. Biological Age Predictors. EBioMedicine 2017, 21, 29–36. [Google Scholar] [CrossRef]
  5. World Health Organization. Envejecimiento y salud [Internet]. 2022. Available from: https://www.who.int/es/news-room/fact-sheets/detail/ageing-and-health.
  6. Lindstrom, M.; Decleene, N.; Dorsey, H.; Fuster, V.; Johnson, C.O.; Legrand, K.E.; et al. Summary of Global Burden of Disease Study Methods. J Am Coll Cardiol. 2022, 80, 2372–2425. [Google Scholar] [CrossRef] [PubMed]
  7. Maas, A.H.E.M.; Rosano, G.; Cifkova, R.; Chieffo, A.; van Dijken, D.; Hamoda, H.; Kunadian, V.; Laan, E.; Lambrinoudaki, I.; Maclaran, K.; et al. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. Eur. Heart J. 2021, 42, 967–984. [Google Scholar] [CrossRef]
  8. Hart, E.C.J.; Charkoudian, N. Sympathetic Neural Regulation of Blood Pressure: Influences of Sex and Aging. Physiology 2014, 29, 8–15. [Google Scholar] [CrossRef] [PubMed]
  9. Fried, L.P.; Tangen, C.M.; Walston, J.; Newman, A.B.; Hirsch, C.; Gottdiener, J.; Seeman, T.; Tracy, R.; Kop, W.J.; Burke, G.; et al. Frailty in Older adults: Evidence for a phenotype. J. Gerontol. Ser. A 2001, 56, M146–M156. [Google Scholar] [CrossRef]
  10. Hoogendijk, E.O.; Afilalo, J.; Ensrud, K.E.; Kowal, P.; Onder, G.; Fried, L.P. Frailty: implications for clinical practice and public health. Lancet 2019, 394, 1365–1375. [Google Scholar] [CrossRef]
  11. Collard, R.M.; Boter, H.; Schoevers, R.A.; Voshaar, R.C.O. Prevalence of Frailty in Community-Dwelling Older Persons: A Systematic Review. J. Am. Geriatr. Soc. 2012, 60, 1487–1492. [Google Scholar] [CrossRef] [PubMed]
  12. Xu, Q.; Ou, X.; Li, J. The risk of falls among the aging population: A systematic review and meta-analysis. Front. Public Heal. 2022, 10, 902599. [Google Scholar] [CrossRef] [PubMed]
  13. Chen, L.; Li, X.; Lv, Y.; Tan, X.; Zhong, V.W.; Rong, S.; Liu, G.; Liu, L. Physical frailty, adherence to ideal cardiovascular health and risk of cardiovascular disease: a prospective cohort study. Age and Ageing 2023, 52. [Google Scholar] [CrossRef] [PubMed]
  14. Yang, Z.-C.; Lin, H.; Jiang, G.-H.; Chu, Y.-H.; Gao, J.-H.; Tong, Z.-J.; Wang, Z.-H. Frailty Is a Risk Factor for Falls in the Older Adults: A Systematic Review and Meta-Analysis. J. Nutr. Heal. Aging 2023, 27, 487–495. [Google Scholar] [CrossRef]
  15. O’halloran, A.M.; Cremers, J.; Vrangbæk, K.; Roe, L.; Bourke, R.; Mortensen, L.H.; Westendorp, R.G.J.; Kenny, R.A. Cardiovascular disease and the risk of incident falls and mortality among adults aged ≥ 65 years presenting to the emergency department: a cohort study from national registry data in Denmark. BMC Geriatr. 2024, 24, 1–11. [Google Scholar] [CrossRef] [PubMed]
  16. World Health Organization. WHO Global Report on Falls Prevention in Older Age. 2007;1–47.
  17. Stevens, J.; Ryan, G.; Kresnow, M. Fatalities and injuries from falls among older adults United States, 1993–2003 and 2001–2005. JAMA Intern Med. 2007, 297, 32–33. [Google Scholar]
  18. Currie, L. Chapter 10. Fall and Injury Prevention. Patient Saf Qual An Evidence-Based Handb Nurses. 2008;1–56.
  19. LeLaurin, J.H.; Shorr, R.I. Preventing Falls in Hospitalized Patients. Clin. Geriatr. Med. 2019, 35, 273–283. [Google Scholar] [CrossRef] [PubMed]
  20. González-María, E.; Moreno-Casbas, M.T.; Albornos-Muñoz, L.; Grinspun, D.; Moreno-Casbas, T.; Abad-Sanz, C.; et al. The implementation of Best practice guidelines in Spain through the Programme of the Best Practice Spot-light Organizations®. Enferm Clin. 2020, 30, 136–144. [Google Scholar] [CrossRef]
  21. Barker, A.L.; Morello, R.T.; Wolfe, R.; A Brand, C.; Haines, T.P.; Hill, K.D.; Brauer, S.G.; Botti, M.; Cumming, R.G.; Livingston, P.M.; et al. 6-PACK programme to decrease fall injuries in acute hospitals: cluster randomised controlled trial. BMJ 2016, 352, h6781. [Google Scholar] [CrossRef] [PubMed]
  22. Morello, R.T.; Barker, A.L.; Ayton, D.R.; Landgren, F.; Kamar, J.; Hill, K.D.; Brand, C.A.; Sherrington, C.; Wolfe, R.; Rifat, S.; et al. Implementation fidelity of a nurse-led falls prevention program in acute hospitals during the 6-PACK trial. BMC Heal. Serv. Res. 2017, 17, 383. [Google Scholar] [CrossRef]
  23. RNAO). RNA of O. Prevención de Caídas y Disminución de Lesiones derivadas de las Caídas. Bpso [Internet]. 2017;103–12. Available from: https://www.bpso.es/wp-content/uploads/2020/01/D0021_Prevencion_Caidas_2017.pdf.
  24. Downton, J. Falls in the elderly. London: Edward Arnold; 1993.
  25. Bueno-García, M.J.; Roldán-Chicano, M.T.; Rodríguez-Tello, J.; Meroño-Rivera, M.D.; Dávila-Martínez, R.; Berenguer-García, N. Características de la escala Downton en la valoración del riesgo de caídas en pacientes hospitalizados. Enferm Clin. 2017, 27, 227–234. [Google Scholar] [CrossRef]
  26. Radloff, L.S. The CES-D Scale: A Self-Report Depression Scale for Researchin the General Population. Appl Psychol Meas. 1977, 1, 385–401. [Google Scholar] [CrossRef]
  27. Ruiz Comellas, A.; Pera, G.; Baena Diez, J.M.; Mundet Tuduri, X.; Alzamora Sas, T.; Elosua, R.; et al. [Validation of a Spanish Short Version of the Minnesota Leisure Time Physical Activity Questionnaire (VREM)]. Rev Esp Salud Publica. 2012, 86, 495–508. [Google Scholar] [PubMed]
  28. Mahoney, F.I.; Barthel, D.W. Functional evaluation: The Barthel Index. Md. State Med. J. 1965, 14, 61–65. [Google Scholar]
  29. Denfeld, Q.E.; Turrise, S.; MacLaughlin, E.J.; Chang, P.-S.; Clair, W.K.; Lewis, E.F.; et al. Preventing and Managing Falls in Adults With Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circ. Cardiovasc. Qual. Outcomes 2022, 15, 458–469. [Google Scholar] [CrossRef]
  30. Richter, D.; Guasti, L.; Walker, D.; Lambrinou, E.; Lionis, C.; Abreu, A.; et al. Frailty in cardiology: Definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardi-ology Practice (CCP), Association for Acute Cardio Vascular Care (ACVC), Association of Cardiovascular Nursing and. Eur J Prev Cardiol. 2022, 29, 216–227. [Google Scholar] [CrossRef]
  31. Del Brutto, O.H.; Mera, R.M.; Peinado, C.D.; Zambrano, M.; Sedler, M.J. Frailty and Risk of Falls in Communi-ty-Dwelling Older Adults Living in a Rural Setting. The Atahualpa Project. J Frailty Aging. 2020, 9, 150–154. [Google Scholar] [CrossRef]
  32. Meyer, G.; Köper, S.; Haastert, B.; Mühlauser, I. Comparison of a fall risk assessment tool with nurses’ judgement alone: a cluster-randomised controlled trial. Age Ageing. 2009, 38, 417–423. [Google Scholar] [CrossRef] [PubMed]
  33. Park, S.-H. Tools for assessing fall risk in the elderly: a systematic review and meta-analysis. Aging Clin. Exp. Res. 2017, 30, 1–16. [Google Scholar] [CrossRef] [PubMed]
  34. Jayanama, K.; Theou, O.; Godin, J.; Cahill, L.; Shivappa, N.; Hébert, J.R.; Wirth, M.D.; Park, Y.-M.; Fung, T.T.; Rockwood, K. Relationship between diet quality scores and the risk of frailty and mortality in adults across a wide age spectrum. BMC Med. 2021, 19, 1–13. [Google Scholar] [CrossRef]
  35. Bu, F.; Deng X hui Zhan N ni Cheng, H.; Wang Z lin Tang, L.; et al. Development and validation of a risk prediction model for frailty in patients with diabetes. BMC Geriatr. 2023, 23, 1–14. [Google Scholar] [CrossRef]
  36. O'Caoimh, R.; Galluzzo, L.; Rodriguez-Laso, A.; Van der Heyden, J.; Ranhoff, A.H.; Lamprini-Koula, M.; Ciutan, M.; Samaniego, L.L.; Carcaillon-Bentata, L.; Kennelly, S.; et al. Prevalence of frailty at population level in European ADVANTAGE Joint Action Member States: a systematic review and meta-analysis. Ann Ist Super Sanità 2018, 54, 226–238. [Google Scholar] [CrossRef]
  37. Galluzzo, L.; O'Caoimh, R.; Rodriguez-Laso, A. Beltzer N, Ciutan AHRJV der HML-KM, Liew LL-S and A. Incidence of frailty: a systematic review of scientific literature from a public health perspective. Ann Ist Super Sanità 2018, 54, 239–245. [Google Scholar]
  38. Wang, X.; Hu, J.; Wu, D. Risk factors for frailty in older adults. Medicine 2022, 101, e30169. [Google Scholar] [CrossRef]
  39. Liperoti, R.; Vetrano, D.L.; Palmer, K.; Targowski, T.; Cipriani, M.C.; Monaco, M.R.L.; Giovannini, S.; Acampora, N.; Villani, E.R.; Bernabei, R.; et al. Association between frailty and ischemic heart disease: a systematic review and meta-analysis. BMC Geriatr. 2021, 21, 1–9. [Google Scholar] [CrossRef] [PubMed]
  40. Denfeld, Q.E.; Winters-Stone, K.; Mudd, J.O.; Gelow, J.M.; Kurdi, S.; Lee, C.S. The prevalence of frailty in heart failure: A systematic review and meta-analysis. Int J Cardiol [Internet] 2017, 236, 283–289. [Google Scholar] [CrossRef] [PubMed]
  41. Gu, Y.; Wan, Y.; Ren, J.-H.; Zhao, Y.; Wang, Y.; Shen, J.-H. Analysis of systolic and diastolic blood pressure variability in frail, pre-frail, and non-frail elderly patients: The relationship between frailty syndrome and blood pressure variability in the elderly. Medicine 2023, 102, e32874. [Google Scholar] [CrossRef] [PubMed]
  42. Vetrano, D.L.; Palmer, K.M.; Galluzzo, L.; Giampaoli, S.; Marengoni, A.; Bernabei, R.; Onder, G. Hypertension and frailty: A systematic review and meta-analysis. BMJ Open 2018, 8, e024406. [Google Scholar] [CrossRef] [PubMed]
  43. Von Elm, E.; Altman, D.G.; Egger, M.; Pocock, S.J.; Gøtzsche, P.C.; Vandenbroucke, J.P.; Initiative, S. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 2007, 370, 1453–1457. [Google Scholar] [CrossRef] [PubMed]
Table 1. Sample description.
Table 1. Sample description.
n=144 Men
n=96
Women
n=48
Frail n=48 Non-frail n=46 Pre-frail
n=50
n n n Total % Total
Diagnosis Arrhythmias
SEX Male 3 3 1 7 4.86%
Female 2 1 5 8 5.56%
Total 5 4 6 15 10.42%
Infectious endocarditis
SEX Male 1 0 1 2 1.39%
Female 0 0 0 0 0.00%
Total 1 0 1 2 1.39%
Heart failure
SEX Male 7 8 6 21 14.58%
Female 5 1 2 8 5.56%
Total 12 9 8 29 20.14%
Coronary heart disease
SEX Male 15 26 20 61 42.36%
Female 8 7 12 27 18.75%
Total 23 33 32 88 61.11%
Heart transplant
SEX Male 1 0 0 1 0.69%
Female 0 0 0 0 0.00%
Total 1 0 0 1 0.69%
Valvular disease
SEX Male 3 0 1 4 2.78%
Female 3 0 2 5 3.47%
Total 6 0 3 9 6.25%
Readmission NO

SEX
Male 23 34 26 83 57.64%
Female 15 8 19 42 29.17%
Total 38 42 45 125 86.81%
YES SEX Male 7 3 3 13 9.03%
Female 3 1 2 6 4.17%
Total 10 4 5 19 13.19%
Diabetes
Mellitus
NO SEX Male 16 27 15 58 40.28%
Female 12 7 15 34 23.61%
Total 28 34 30 92 63.89%
YES SEX Male 14 10 14 38 26.39%
Female 6 2 6 14 9.72%
Total 20 12 20 52 36.11%
Chest pain NO
SEX Male 19 23 22 64 44.44%
Female 12 5 12 29 20.14%
Total 31 28 34 93 64.58%
YES SEX Male 11 14 7 32 22.22%
Female 6 4 9 19 13.19%
Total 17 18 16 51 35.42%
Dyspnoea NO
SEX Male 18 28 21 67 46.53%
Female 12 7 14 33 22.92%
Total 30 35 35 100 69.44%
YES SEX Male 12 9 8 29 20.14%
Female 6 2 7 15 10.42%
Total 18 11 15 44 30.56%
Risk of falls (Downton) NO
SEX Male 0 2 1 3 2.08%
Female 1 0 0 1 0.69%
Total 1 2 1 4 2.78%
YES SEX Male 30 35 28 93 64.58%
Female 17 9 21 47 32.64%
Total 47 44 49 140 97.22%
High/Very high risk of falls (Downton
>3)
YES SEX Male 16 12 6 34 35.42%
Female 8 3 8 21 39.58%
Total 24 15 14 53 36.81%
Low/Moderate risk of falls
(Downton
1–2)

YES
SEX Male 14 23 22 59 61.46%
Female 9 6 13 16 33.33%
Total 23 29 35 87 60.42%
Table 2. Descriptive statistics for quantitative variables in the total sample.
Table 2. Descriptive statistics for quantitative variables in the total sample.
n Mean ( X ¯ ) Standard deviation (SD) Sex n Mean ( X ¯ ) Standard deviation (SD)
Age (years) 144 73.08 7.95 Male 96 73.14 7.94
Female 48 72.98 8.06
Downton (points) 144 2.24 1.25 Male 96 2.25 1.26
Female 48 2.21 1.24
Barthel index (points) 144 95.76 9.28 Male 96 96.88 6.70
Female 48 93.54 12.80
Oxygen saturation (%) 144 94.99 2.58 Male 96 94.85 2.83
Female 48 95.27 2.01
Heart rate (bpm) 144 73.47 16.34 Male 96 71.97 16.31
Female 48 76.46 16.14
Systolic blood pressure (mmHg) 144 124.17 19.59 Male 96 125.84 18.34
Female 48 120.83 21.71
Diastolic blood pressure (mmHg) 144 70.84 10.21 Male 96 71.92 9.96
Female 48 68.69 10.48
Blood glucose (mg/dl) 144 134.62 52.78 Male 96 134.91 49.35
Female 48 134.04 59.61
Waist circumference (cm) 144 102.96 12.83 Male 96 104.83 10.82
Female 48 99.13 15.62
Length of stay (days) 144 8.66 5.56 Male 96 9.40 6.13
Female 48 7.11 3.78
Height (cm) 144 164.44 7.87 Male 96 168.15 5.81
Female 48 157.02 5.99
144 74.99 13.56 Male 96 78.36 12.76
Weight (kg) Female 48 68.25 12.68
144 27.69 4.35 Male 96 27.71 4.09
BMI (kg/m2) Female 48 27.67 4.89
Table 3. Distribution of frailty status according to Fried’s criteria by sex and length of hospital stay.
Table 3. Distribution of frailty status according to Fried’s criteria by sex and length of hospital stay.
Frailty status SEX Total n=144
Men
n=96
Length of stay (days)
X ¯ (SD)
Women
n=48
Length of stay
(days)
X ¯ (SD)
Frail 31.30% 12.35 (8.23) 37.50% 7.86 (2.53) 33.30%
Non-frail 38.50% 7.33 (4.29) 18.80% 5.71 (2.13) 31.90%
Pre-frail 30.20% 9.14 (5.64) 43.80% 7.42 (4.47) 34.70%
Table 4. Distribution of total categorical variables by sex and frailty status.
Table 4. Distribution of total categorical variables by sex and frailty status.
Categorical variables % n=144 SEX
(men: n=96; women: n=48)
%
within SEX
Frail Non-frail Pre-frail
Diagnosis Arrythmias 10.42% Male 7.29% 3.13% 3.13% 1.04%
Female 16.67% 4.17% 2.08% 10.42%
Total 7.29% 5.21% 11.46%
Infectious endocarditis 1.39% Male 2.08% 1.04% 0.00% 1.04%
Female 0.00% 0.00% 0.00% 0.00%
Total 1.04% 0.00% 1.04%
Heart failure 20.14% Male 21.88% 7.29% 8.33% 6.25%
Female 16.67% 10.42% 2.08% 4.17%
Total 17.71% 10.42% 10.42%
Coronary heart disease 61.11% Male 63.54% 15.63% 27.08% 20.83%
Female 56.25% 16.67% 14.58% 25.00%
Total 32.29% 41.67% 45.83%
Heart transplant 0.69% Male 1.04% 1.04% 0.00% 0.00%
Female 0.00% 0.00% 0.00% 0.00%
Total 1.04% 0.00% 0.00%
Valvular disease 6.25% Male 4.17% 3.13% 0.00% 1.04%
Female 10.42% 6.25% 0.00% 4.17%
Total 9.38% 0.00% 5.21%
Readmission NO 86.81% Male 89.58% 23.96% 35.42% 27.08%
Female 87.50% 31.25% 16.67% 39.58%
Total 55.21% 52.08% 66.67%
YES 13.19% Male 13.54% 7.29% 3.13% 3.13%
Female 12.50% 6.25% 2.08% 4.17%
Total 13.54% 5.21% 7.29%
Diabetes mellitus NO 63.89% Male 60.42% 16.67% 28.13% 15.63%
Female 70.83% 25.00% 14.58% 31.25%
Total 41.67% 42.71% 46.88%
YES 36.11% Male 39.58% 14.58% 10.42% 14.58%
Female 29.17% 12.50% 4.17% 12.50%
Total 27.08% 14.58% 27.08%
Chest pain NO 64.58% Male 66.67% 19.79% 23.96% 22.92%
Female 60.42% 25.00% 10.42% 25.00%
Total 44.79% 34.38% 47.92%
YES 35.42% Male 33.33% 11.46% 14.58% 7.29%
Female 39.58% 12.50% 8.33% 18.75%
Total 23.96% 22.92% 26.04%
Dyspnoea NO 69.44% Male 69.79% 18.75% 29.17% 21.88%
Female 68.75% 25.00% 14.58% 29.17%
Total 43.75% 43.75% 51.04%
YES 30.56% Male 30.21% 12.50% 9.38% 8.33%
Female 31.25% 12.50% 4.17% 14.58%
Total 25.00% 13.54% 22.92%
Risk of falls (Downton) NO 2.78% Male 3.13% 0.00% 2.08% 1.04%
Female 2.08% 2.08% 0.00% 0.00%
Total 2.08% 2.08% 1.04%
YES 97.22% Male 96.98% 31.25% 36.46% 29.17%
Female 97.92% 35.42% 18.75% 43.75%
Total 66.67% 55.21% 72.92%
Table 5. Distribution of frailty status in the total high/very high fall risk group and by sex.
Table 5. Distribution of frailty status in the total high/very high fall risk group and by sex.
Fried SEX Total (n=53)
Male (n=34) Female (n=19)
Frail % within SEX 47.10% 42.10% 45.30%
Non-frail % within SEX 35.30% 15.80% 28.30%
Pre-frail % within SEX 17.60% 42.10% 26.40%
Table 6. Distribution of the most common medications used by patients assessed with the J.H. Downton scale.
Table 6. Distribution of the most common medications used by patients assessed with the J.H. Downton scale.
Type of medication % (n=144)
Antihypertensives 2.80
Non-diuretic antihypertensives 14.60
Antidepressants 0.70
Antiparkinsonians 2.10
Diuretics 3.50
Tranquillisers/sedatives 6.30
Diuretics and antihypertensives 3.50
Diuretics and non-diuretic antihypertensives 3.50
Diuretics and antidepressants 0.70
Diuretics and other medications 2.80
Other medications and non-diuretic antihypertensives 16.00
Tranquillisers/sedatives and non-diuretic antihypertensives 1.40
Tranquillisers/sedatives and other medications 1.40
Tranquillisers/sedatives, other medications, and non-diuretic antihypertensives 2.10
Diuretics, other medications, and non-diuretic antihypertensives 7.30
Tranquillisers/sedatives, antiparkinsonians, antidepressants, other medications, and non-diuretic antihypertensives 0.70
Other medications 27.10
None 3.50
Table 7. Association between frailty groups and demographic and clinical variables.
Table 7. Association between frailty groups and demographic and clinical variables.
Fried Variable Test statistic Dev. Error Dev. Test statistic p-value
Non-frail–Pre-frail Downton score -3.70 8.22 -0.45 0.65
Non-frail–Frail 21.45 8.30 2.58 0.01
Pre-frail–Frail 17.74 8.13 2.18 0.03
Frail–Pre-frail Barthel index -24.58 6.64 -3.69 0.00
Frail–Non-frail -32.92 6.78 -4.85 0.00
Pre-frail–Non-frail 8.34 6.72 1.24 0.21
Non-frail–Pre-frail Length of hospital stay -8.67 7.43 -1.17 0.24
Non-frail–Frail 19.58 7.43 2.64 0.00
Pre-frail–Frail 10.90 7.43 1.47 0.14
Pre-frail–Non-frail Waist circumference 1.00 8.46 0.12 0.91
Pre-frail–Frail 19.65 8.41 2.34 0.02
Non-frail–Frail 18.65 8.59 2.17 0.03
Pre-frail–Non-frail Age 11.15 8.51 1.31 0.19
Pre-frail–Frail 36.62 8.42 4.35 0.00
Non-frail–Frail 25.47 8.60 2.96 0.00
Frail–Pre-frail Height (cm2) -8.00 8.42 -0.95 0.34
Frail–Non-frail -22.08 8.60 -2.57 0.01
Pre-frail–Non-frail 14.08 8.51 1.65 0.10
Table 8. Analysis of sociodemographic and clinical variables influencing frailty status in patients with cardiac conditions
Table 8. Analysis of sociodemographic and clinical variables influencing frailty status in patients with cardiac conditions
Clinical and sociodemographic variables β Error Standard Error Wald df p Exp(β) (Odds Ratio) 95% CI for Exp(β)
Lower limit Upper limit
Age 0.108 0.026 16.734 1 0.000 1.114 1.058 1.173
Sex (female) 0.278 0.371 0.561 1 0.454 1.320 0.638 2.729
Sex (male) -0.278 0.371 0.561 1 0.454 0.758 0.366 1.566
Risk of falls (YES) -0.427 0.836 0.261 1 0.609 0.652 0.127 3.360
Downton score 0.448 0.155 8.385 1 0.004 1.565 1.156 2.120
Readmission 0.934 0.499 3.502 1 0.061 2.544 0.957 6.764
Diabetes (YES) 0.357 0.364 0.959 1 0.327 1.429 0.700 2.916
Chest pain (YES) 0.000 0.370 0.000 1 1.000 1.000 0.485 2.064
Dyspnoea (YES) 0.480 0.376 1.624 1 0.203 1.615 0.773 3.378
Barthel index -0.103 0.028 13.503 1 0.000 0.902 0.854 0.953
Oxygen saturation (SpO2) -0.140 0.073 3.713 1 0.054 0.869 0.754 1.002
Heart rate 0.001 0.011 0.003 1 0.960 1.001 0.980 1.022
Systolic blood pressure 0.006 0.009 0.385 1 0.535 1.006 0.988 1.024
Diastolic blood pressure -0.037 0.018 4.247 1 0.039 0.963 0.930 0.998
Blood glucose 0.001 0.003 0.158 1 0.691 1.001 0.995 1.008
Length of stay 0.096 0.038 6.318 1 0.012 1.101 1.021 1.186
Waist circumference 0.031 0.015 4.352 1 0.037 1.031 1.002 1.062
BMI 0.061 0.041 2.225 1 0.136 1.063 0.981 1.152
Table 9. Relationship between frailty status (frail–non-frail) and the Downton scale items
Table 9. Relationship between frailty status (frail–non-frail) and the Downton scale items
J.H. Downton scale items β Error Standard error Wald df p Exp(β) (Odds Ratio) 95% CI for Exp(β)
Inferior Superior
Previous falls (YES) 0.000 0.535 0.000 1 1.000 1.000 0.351 2.851
Medications (diuretics) 1.447 0.680 4.525 1 0.033 4.250 1.120 16.120
Sensory deficit (extremities) 2.084 1.178 3.130 1 0.077 8.040 0.799 80.943
Mental state (confused) 21.917 40192.969 0.000 1 1.000 3299693296.036 0.000
Gait (normal) -1.361 0.474 8.249 1 0.004 0.256 0.101 0.649
Table 10. Relationship between frailty status (frail–non-frail) and clinical diagnoses at admission
Table 10. Relationship between frailty status (frail–non-frail) and clinical diagnoses at admission
Diagnoses β Error Standard error Wald df p Exp(β) (Odds Ratio) 95% CI for Exp(β)
Lower limit Upper limit
Arrhythmias -1.386 0.894 2.402 1 0.121 0.250 0.043 1.443
Infectious endocarditis -0.693 1.581 0.192 1 0.661 0.500 0.023 11.088
Heart failure -1.041 0.801 1.689 1 0.194 0.353 0.073 1.698
Coronary heart disease -1.732 0.748 5.368 1 0.021 0.177 0.041 0.766
Heart transplant 20.510 40192.969 0.000 1 1.000 807737421.426 0.000
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated